Liberian doctor dies after experimental Ebola drug
A Liberian doctor who received one of the last known doses of ZMapp, an untested Ebola treatment, has died after showing initial improvement. Six people globally are known to have received ZMapp. U.S. maker has limited supply and months are expected before more doses. The story covers patient outcomes, vaccine prospects, and international responses including WHO and Canada.
MENTIONED IN THIS ARTICLE
Monrovia. Liberia
Canada
West Africa
Patrick Gaebel
Public Health Agency of Canada
World Health Organization
Gaebel
U.S
Abraham Barber
Liberia
Barbera
Lewis Brown
Associated Press
Atlanta
Also Mentioned on This Page
Hig
Pee ER
Eric DiNovo
Freshcoat
Brian Dalton
Northfork
South Central Education Developmental Center
Bluefield
Cceiaseccpeensnissenes
Hyundai
Bill Cole
Princeton
BillColeHyundai.com
Bob Reilles
America
Hyunda Rinceton
William Pooley
London
Royal Free Hospital
Sierra Leone
Pooley
Britain
Allergy E Asthma
Donald W. Asbury
M.D
Hockman Pike
WHO
Keiji Fukada
U.N
Stephane Dujarric
Japan
Avigan
Fujifilm
Toyama Chemical Co
The
Bluefield Daily Telegraph
Bdtonline
Ally
iPad
Bdtonline.com